期刊文献+

胃癌中异位病毒整合位点-1的表达及临床意义

Expression of ecotropic viral integration site-1 in human gastric cancer and its clinical significance
在线阅读 下载PDF
导出
摘要 目的探讨异位病毒整合位点-1(EVI-1)在胃癌中的表达及临床意义。方法采用免疫组织化学法检测胃癌组织和癌旁组织中EVI-1蛋白的表达情况;采用蛋白质印迹法(Western blot)和实时荧光定量逆转录聚合酶链反应,分别检测人胃癌细胞株AGS、NCI-N87、MGC-803、HGC27和永生化正常胃黏膜细胞株GES-1中EVI-1的3个剪切变异体蛋白(MDS1/EVI-1、EVI-1、EVI-1△324)和EVI-1 mRNA(除MGC-803)的表达水平。结果胃癌组织中EVI-1蛋白的阳性表达率为76.7%(46/60),明显高于癌旁正常胃组织的41.7%(25/60),差异有统计学意义(P﹤0.01)。胃癌细胞中MDS1/EVI-1和EVI-1蛋白相对表达量均高于正常胃黏膜上皮细胞,差异均有统计学意义(P﹤0.05);MGC-803、AGS胃癌细胞中EVI-1△324蛋白相对表达量也高于正常胃黏膜上皮细胞,但差异无统计学意义(P﹥0.05)。HGC27、NCI-N87、AGS细胞株中EVI-1 mRNA相对表达量均高于GES-1细胞株,差异均有统计学意义(P﹤0.05)。结论胃癌中EVI-1蛋白(除EVI-1△324亚型)和EVI-1 mRNA的表达均较癌旁正常胃黏膜组织高。EVI-1基因可能是潜在的胃癌原癌基因,尚有待进一步深入研究。 Objective To investigate the expression of ecotropic viral integration site-1(EVI-1)in gastric cancer and its clinical significance.Method The expression of EVI-1 protein in gastric cancer tissues and its adjacent normal tissues were detected by immunohistochemistry(IHC).The expression of EVI-1 splice variant proteins(MDS1/EVI-1、EVI-1 and EVI-1△324)and EVI-1 mRNA in both four gastric cancer cell lines(AGS,NCI-N87,MGC-803,HGC27)and normal gastric mucosal immortalized cells(GES-1)were detected by Western blot and real-time quantitative reverse transcription-polymerase chain reaction(qRT-PCR),respectively.Result At the histological level,the positive expression rate of EVI-1 in gastric cancer tissues was higher than that in adjacent normal tissues[76.7%(46/60)vs 41.7%(25/60),P<0.01].The relative expression levels of MDS1/EVI-1 and EVI-1 in gastric cancer cells were higher than those in normal gastric epithelial cells(P<0.05).The relative expression of EVI-1△324 protein in MGC-803 and AGS gastric cancer cells were also higher than that in normal gastric epithelial cells,but the difference was not statistically significant(P>0.05).The relative expression levels of EVI-1 mRNA in HGC27,NCI-N87 and AGS cell lines were significantly higher than those in GES-1 cell lines(P<0.05).Conclusion The expression of EVI-1 protein(except for EVI-1△324 subtype)and EVI-1 mRNA in gastric cancer were higher than those in adjacent normal gastric mucosa.EVI-1 may be a potential proto-oncogene which is needed to be further studied.
作者 黄燕美 秦攀 张凤 王海燕 陈淑勤 HUANG Yanmei;QIN Pan;ZHANG Feng;WANG Haiyan;CHEN Shuqin(Department of Pathology,School of Basic Medical Sciences,Fujian Medical University,Fuzhou 350004,Fujian,China;Institute of Oncology,Fujian Medical University,Fuzhou 350004,Fujian,China;Diagnostic Pathology Center,Fujian Medical University,Fuzhou 350004,Fujian,China)
出处 《癌症进展》 2021年第1期31-34,95,共5页 Oncology Progress
关键词 异位病毒整合位点-1 胃癌 免疫组织化学 蛋白质印迹法 实时荧光定量逆转录聚合酶链反应 ecotropic viral integration site-1 gastric cancer immunohistochemistry Western blot real-time quantitative reverse transcription-polymerase chain reaction
  • 相关文献

参考文献3

二级参考文献20

  • 1BARTHOLOMEW C, CLARK AM. Induction of two alternatively spliced evi-1 proto-oncogene transcripts by cAMP in kidney cells[J]. Oncogene, 1994, 9(3): 939-942.
  • 2RIMANN I, HAJNAL A. Regulation of anchor cell invasion and uterine cell fates by the egl-43 Evi-1 proto-oncogene in Caenorhabditis elegans[J]. Dev Biol, 2007, 308(1): 187-195.
  • 3VINATZER U, TAPLICK J, SEISER C, et al. The leukaemi- a-associated transcription factors Evi-1 and MDS1/Evi-1 repress transcription and interact with histone deacetylase [J]. Br J Haematol, 2001, 114(3): 566-573.
  • 4AL-Hajj M, Wieha MS, Benito-Hernandez A, et al. Prospective iden- tification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci USA,2003,100(7) :3983-3988.
  • 5Knoop AS, Kudsen H, Balslev E, et al. Retrospetive analysis of topoisomerase II a amplifications and deletions as predictive mark- ers in primary breast cancer patients randomly assigned to cyclo- phosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group [ J ]. J Clin Oneol, 2005,23 (30) : 7483-7490.
  • 6Tanner M, Isola J, Wiklund T, et al. Topoisomerase 1I alpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER- 2/neu- amplified breast cancer: Scandinavian Breast Group Trial 9401 [J ]. J Clin Oncol, 2006,24(16) : 2428-2436.
  • 7Harrison H, Farnie G, Howell SJ, et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor[J]. Can- cer Res,2010,70(2) :709-718.
  • 8Guo J, Zhou J, Ying X, et al. Effects of stealth liposomal daunorubi- cin plus tamoxifen on the breast cancer and stem ceils [J]. J Pharm Sci,2010,13(2) : 136-151.
  • 9Sheridan C, Kishimoto H, Fuchs RK, et al. CD44~/CD24- breast can- cer cells exhibit enhanced invasive properties : an early step neces- sary for metastasis [ J ]. Breast Cancer Res, 2006,8 (5) : R59.
  • 10Sayed D, Abdellatif M. MicroRNAs in development and Physiol Rev, 2011,91 (3) : 827-887.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部